BioAge Labs reported total assets of $396.93M and total liabilities of $22.02M for the quarter ended Jun 2026, up 23.2% year over year. This balance sheet covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.42M | 0.54M | 0.37M | 0.41M | 0.46M | 0.41M | 0.48M | 0.54M | 0.61M | |||
| Receivables - AccuredAcc. Int. Receivables | 1.20M | 1.10M | 1.00M | 1.10M | 1.20M | 1.90M | 2.50M | |||||
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash & EquivalentsCash & Equiv. | 21.64M | 173.99M | 334.50M | 354.35M | 335.10M | 313.40M | 295.90M | 188.89M | 384.90M | 381.30M | ||
| Receivables - NetNet Receivables | 0.36M | 0.60M | 0.52M | 0.77M | 0.71M | 0.62M | ||||||
| Receivables | 0.36M | 0.60M | 0.52M | 0.77M | 0.71M | 0.62M | ||||||
| Prepaid Assets | 0.35M | 1.99M | 2.75M | 3.93M | 3.80M | 4.54M | 4.93M | 7.96M | 10.94M | |||
| Current Assets | 25.31M | 336.47M | 357.10M | 324.81M | 301.70M | 290.83M | 286.79M | 391.86M | 330.31M | |||
| Non-Current Assets | ||||||||||||
| Property, Plant & Equipment (Net) | 0.32M | 0.54M | 0.59M | 0.93M | 0.97M | 0.97M | 0.96M | 1.11M | 1.21M | |||
| Long-Term Investments | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | |||
| Other Non-Current Assets | 3.30M | 0.24M | 0.24M | 0.24M | 0.23M | 0.22M | 0.21M | 0.21M | ||||
| Non-Current Assets | 0.62M | 0.91M | 1.13M | 19.03M | 20.45M | 14.26M | 8.10M | 5.79M | 66.62M | |||
| Assets | 25.92M | 337.38M | 358.23M | 343.84M | 322.15M | 305.09M | 294.89M | 397.65M | 396.93M | |||
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payables | 1.87M | 2.10M | 2.00M | 3.99M | 1.33M | 5.02M | 2.67M | 3.07M | 5.65M | |||
| Payables | 1.87M | 2.10M | 2.00M | 3.99M | 1.33M | 5.02M | 2.67M | 3.07M | 5.65M | |||
| Accumulated Expenses | 7.94M | 10.71M | 11.75M | 4.87M | 7.58M | 7.26M | 8.48M | 4.76M | 8.49M | |||
| Other Accumulated Expenses | 1.39M | 1.74M | 0.42M | 0.56M | 0.91M | 0.89M | 0.53M | 0.71M | 0.39M | |||
| Short term Debt | 6.00M | 6.00M | 6.00M | 6.00M | 5.60M | 4.13M | 2.65M | 1.16M | ||||
| Current Leases | 0.19M | 0.27M | 0.20M | 0.70M | 0.63M | 0.58M | 0.58M | 0.65M | 0.71M | |||
| Current Deferred Revenue | 3.31M | 7.83M | 8.18M | 7.70M | 7.51M | 5.75M | 6.19M | 4.36M | ||||
| Total Current Liabilities | 58.17M | 19.08M | 27.77M | 23.74M | 22.84M | 24.49M | 20.14M | 15.83M | 19.22M | |||
| Non-Current Liabilities | ||||||||||||
| Non-Current Debt | 8.20M | 3.94M | 2.50M | 1.06M | ||||||||
| Non-Current Deffered Revenue | 4.67M | 3.23M | 1.90M | 0.56M | ||||||||
| Preferred Stock Liabilities | 132.72M | 132.72M | 342.83M | 342.83M | ||||||||
| Operating Leases | 2.56M | 2.52M | 2.43M | 2.33M | 2.23M | 2.12M | ||||||
| Other Non-Current Liabilities | 0.23M | 0.61M | 0.16M | 0.10M | 0.11M | 0.15M | 0.37M | 0.48M | 0.68M | |||
| Total Non-Current Liabilities | 66.37M | 23.02M | 34.95M | 30.58M | 27.26M | 27.48M | 22.47M | 18.06M | 21.34M | |||
| Total Liabilities | 153.14M | 66.60M | 185.51M | 197.13M | 23.63M | 35.11M | 30.67M | 27.37M | 27.63M | 22.84M | 18.53M | 22.02M |
| Shareholder's Equity | ||||||||||||
| Total Debt | 14.20M | 9.94M | 8.50M | 7.06M | 5.60M | 4.13M | 2.65M | 1.16M | ||||
| Common Equity | -153.14M | -173.40M | -185.51M | -197.13M | 313.75M | 323.13M | 313.17M | 294.78M | 277.46M | 272.05M | 379.12M | 374.91M |
| Liabilities and Shareholders Equity | 25.92M | 337.38M | 358.23M | 343.84M | 322.15M | 305.09M | 294.89M | 397.65M | 396.93M | |||
| Retained Earnings | -181.70M | 545.32M | 575.69M | 578.64M | 581.87M | 584.66M | 605.19M | 734.72M | 757.16M | |||
| Treasury Shares | 31.47M | 31.47M | 93.07M | 93.07M |